170 related articles for article (PubMed ID: 892004)
1. Development of drug therapy for children.
Cohen SN
Fed Proc; 1977 Sep; 36(10):2356-8. PubMed ID: 892004
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics.
Pediatrics; 1995 Feb; 95(2):286-94. PubMed ID: 7838651
[No Abstract] [Full Text] [Related]
3. American Academy of Pediatrics. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations.
Pediatrics; 1977 Jul; 60(1):91-101. PubMed ID: 876741
[No Abstract] [Full Text] [Related]
4. Nondevelopmental research on human subjects: the impact of the recommendations of the National Commission.
Levine RJ
Fed Proc; 1977 Sep; 36(10):2359-64. PubMed ID: 892005
[No Abstract] [Full Text] [Related]
5. Research involving children: Recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
Jonsen AR
Pediatrics; 1978 Aug; 62(2):131-6. PubMed ID: 693150
[No Abstract] [Full Text] [Related]
6. Development of drug therapy for the mentally ill.
Klerman GL
Fed Proc; 1977 Sep; 36(10):2352-5. PubMed ID: 892003
[No Abstract] [Full Text] [Related]
7. The paradoxical case of payment as benefit to research subjects.
Macklin R
IRB; 1989; 11(6):1-3. PubMed ID: 11650284
[No Abstract] [Full Text] [Related]
8. Consent in pediatric medical experimentation.
Nelson FK; Bernstein JE
J Leg Med (N Y); 1975 Mar; 3(3):15-9. PubMed ID: 1079818
[No Abstract] [Full Text] [Related]
9. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
10. FDA revises informed consent regulations for emergency research.
Menasché A; Levine RJ
IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
[No Abstract] [Full Text] [Related]
11. Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical?
Cho MK
IRB; 1994; 16(1-2):12-5. PubMed ID: 11652321
[No Abstract] [Full Text] [Related]
12. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
13. The National Commission and research in pharmacology: an overview.
Lebacqz K
Fed Proc; 1977 Sep; 36(10):2344-8. PubMed ID: 892001
[TBL] [Abstract][Full Text] [Related]
14. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
15. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
16. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
17. Federal agency proposal will lead to more children serving as research subjects.
Maloney DM
Hum Res Rep; 1997 Oct; 12(10):1-2. PubMed ID: 11656894
[No Abstract] [Full Text] [Related]
18. Constraints on experimentation: protecting children to death.
Holder AR
Yale Law Policy Rev; 1988; 6(1):137-56. PubMed ID: 11650241
[No Abstract] [Full Text] [Related]
19. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
20. Multicenter trials and subject eligibility: should local IRBs play a role?
Freedman B
IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
